Prolight Diagnostics has developed a breakthrough point-of-care system that delivers reliable test results in 10 minutes or less, right at the patient´s side.
Driving efficiency and accelerating time to clinical decision.
Watch the video (https://youtu.be/WVNC8vKRdWA) to discover why our proprietary, patent-protected technology is at the heart of the next major shift in healthcare.
For further information, please contact:
Ulf Bladin, CEO
E-mail: info@prolightdx.com
Phone: +46 73 582 39 87
Company website: www.prolightdx.com
About Us
Prolight Diagnostics AB develops innovative Point-of-Care (POC) systems. These are small, portable instruments and disposable cartridges for performing in-vitro diagnostic (IVD) tests from a drop of blood.
We want to offer the foremost POC systems on the market for quick, reliable diagnosis of acute events. Our launch product will be for the measurement of troponin, to aid in the rule-in and rule-out of myocardial infarction.
The company’s share is traded on the NGM Nordic SME marketplace, under the ticker PRLD.